{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:22:25Z","timestamp":1768742545523,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:00:00Z","timestamp":1293062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Trans\u2010scleral cyclophotocoagulation with diode laser has been well documented in the management of neovascular glaucoma. More recently, intravitreal bevacizumab has been increasingly employed to treat neovascular diseases of the eye. This study reports our initial experience with trans\u2010scleral cyclophotocoagulation alone <jats:italic>versus<\/jats:italic> the combination of trans\u2010scleral cyclophotocoagulation and intravitreal bevacizumab for management of neovascular glaucoma.<\/jats:p><jats:p><jats:bold>Design:\u2002<\/jats:bold> Retrospective uncontrolled comparative case series<\/jats:p><jats:p><jats:bold>Participants:\u2002<\/jats:bold> A total of 31 eyes of 30 consecutive patients were included \u2013 11 eyes in the trans\u2010scleral cyclophotocoagulation alone group and 20 in the combination trans\u2010scleral cyclophotocoagulation and intravitreal bevacizumab group.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The records of all patients diagnosed with neovascular glaucoma undergoing trans\u2010scleral cyclophotocoagulation with or without intravitreal bevacizumab performed by a single ophthalmic surgeon in a glaucoma specialist centre were reviewed.<\/jats:p><jats:p><jats:bold>Main Outcome Measures:\u2002<\/jats:bold> Data collected included intraocular pressure, anterior segment neovascularisation, best\u2010corrected visual acuity, use of medications and complications.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Mean reduction in intraocular pressure was 33.5\u2003mmHg in the trans\u2010scleral cyclophotocoagulation group and 23.7\u2003mmHg in the combination group, a difference of 9.8\u2003mmHg (95% CI \u22121.5, 21.1). Complications included hypotony in three (27%) eyes in the trans\u2010scleral cyclophotocoagulation group and two (10%) eyes in the combination group. Three eyes required evisceration.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Trans\u2010scleral cyclophotocoagulation alone is effective in lowering intraocular pressure in neovascular glaucoma. In this study, the addition of intravitreal bevacizumab to trans\u2010scleral cyclophotocoagulation did not statistically advantage treatment outcomes.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2010.02449.x","type":"journal-article","created":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T15:34:42Z","timestamp":1288020882000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone <i>versus<\/i> combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab"],"prefix":"10.1111","volume":"39","author":[{"given":"Anthony W","family":"Fong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham A","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30508-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31817d235c"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.116533"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199902000-00003"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.02.026"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2010.02285.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2010.02300.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.12.009"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00775-8"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1990.tb00611.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181679c0b"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30938-4"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1983.01040010745008"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00810.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702125"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)30904-9"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.129833"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01355.x"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2010.02449.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2010.02449.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:24:53Z","timestamp":1697383493000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2010.02449.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1442-9071.2010.02449.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02449.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,23]]},"assertion":[{"value":"2010-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}